-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$17.25439.06% Upside
Prime Medicine, Inc. Frequently Asked Questions
-
What analysts cover Prime Medicine, Inc.?
Prime Medicine, Inc. has been rated by research analysts at Jefferies, Wedbush, BMO Capital, Morgan Stanley in the past 90 days.